Information, not a decision

Acute myeloid leukemia: tumour board sheet

Dated public registry data. It contains no treatment recommendation. 12 Nov 2026

Open trials (835)

NCT03589729	Phase 2	Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers	Recruiting
NCT05436418	Phase 1/2	The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation	Recruiting
NCT03263572	Phase 2	Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia	Recruiting
NCT07929740	Phase 1	Bioavailability and Bioequivalence Study of Ziftomenib in Participants With Relapsed/Refractory AML or MDS	Not yet recruiting
NCT06930352	Phase 2	Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy	Recruiting
NCT04986657	No phase	Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS	Recruiting
NCT07925554	Phase 2	Interferon-α Maintenance in Favorable-Risk AML	Recruiting
NCT06252584	Phase 1	Multi-peptide Vaccination Adjuvanted With XS15 in Acute Myeloid Leukemia Patients	Recruiting
NCT07925190	Phase 3	A Phase III Study Comparing Mesutoclax + Azacitidine Versus Venetoclax + Azacitidine in Untreated Acute Myeloid Leukemia (AML) Patients	Not yet recruiting
NCT05554406	Phase 2	Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)	Recruiting
NCT07926607	Phase 1/2	Palbociclib, All-Trans Retinoic Acid, and Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia	Not yet recruiting
NCT05672147	Phase 1	CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia	Recruiting

823 more in the doctor's list on the site.

Phase 3 trials that ended in the last 90 days

No phase 3 trial in this list ended in the last 90 days.

Guidelines

Links only: read the guideline itself.

Made from the public data of Frontlight Research. Source: ClinicalTrials.gov. 12 Nov 2026

https://frontlightresearch.com/en/doctor/acute-myeloid-leukemia/tumor-board